These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 34561691)

  • 1. A practical guide to large-scale docking.
    Bender BJ; Gahbauer S; Luttens A; Lyu J; Webb CM; Stein RM; Fink EA; Balius TE; Carlsson J; Irwin JJ; Shoichet BK
    Nat Protoc; 2021 Oct; 16(10):4799-4832. PubMed ID: 34561691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-source drug discovery platform enables ultra-large virtual screens.
    Gorgulla C; Boeszoermenyi A; Wang ZF; Fischer PD; Coote PW; Padmanabha Das KM; Malets YS; Radchenko DS; Moroz YS; Scott DA; Fackeldey K; Hoffmann M; Iavniuk I; Wagner G; Arthanari H
    Nature; 2020 Apr; 580(7805):663-668. PubMed ID: 32152607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Techniques Made Simple: Molecular Docking in Dermatology - A Foray into In Silico Drug Discovery.
    Issa NT; Badiavas EV; Schürer S
    J Invest Dermatol; 2019 Dec; 139(12):2400-2408.e1. PubMed ID: 31753122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Software Used and the Type of Target Protein on Molecular Docking Accuracy.
    Ivanova L; Karelson M
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing and improving the performance of consensus docking strategies using the DockBox package.
    Preto J; Gentile F
    J Comput Aided Mol Des; 2019 Sep; 33(9):817-829. PubMed ID: 31578656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico fragment-based drug design with SEED.
    Marchand JR; Caflisch A
    Eur J Med Chem; 2018 Aug; 156():907-917. PubMed ID: 30064119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence-enabled virtual screening of ultra-large chemical libraries with deep docking.
    Gentile F; Yaacoub JC; Gleave J; Fernandez M; Ton AT; Ban F; Stern A; Cherkasov A
    Nat Protoc; 2022 Mar; 17(3):672-697. PubMed ID: 35121854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIt Discovery using docking ENriched by GEnerative Modeling (HIDDEN GEM): A novel computational workflow for accelerated virtual screening of ultra-large chemical libraries.
    Popov KI; Wellnitz J; Maxfield T; Tropsha A
    Mol Inform; 2024 Jan; 43(1):e202300207. PubMed ID: 37802967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
    Morency LP; Gaudreault F; Najmanovich R
    Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation.
    Shaker B; Yu MS; Lee J; Lee Y; Jung C; Na D
    J Microbiol; 2020 Mar; 58(3):235-244. PubMed ID: 32108318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Docking.
    Sulimov VB; Kutov DC; Sulimov AV
    Curr Med Chem; 2019; 26(42):7555-7580. PubMed ID: 30182836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Virtual Screening of Commercially Available Compound Libraries.
    Kireev D
    Methods Mol Biol; 2016; 1439():65-76. PubMed ID: 27316988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-Ligand Docking in Drug Design: Performance Assessment and Binding-Pose Selection.
    Ballante F
    Methods Mol Biol; 2018; 1824():67-88. PubMed ID: 30039402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Learning with Geometry-Enhanced Molecular Representation for Augmentation of Large-Scale Docking-Based Virtual Screening.
    Yu L; He X; Fang X; Liu L; Liu J
    J Chem Inf Model; 2023 Nov; 63(21):6501-6514. PubMed ID: 37882338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years.
    Zhu H; Zhang Y; Li W; Huang N
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative Image-Based Screening: Rigid Docking Using Cavity Information.
    Postila PA; Kurkinen ST; Pentikäinen OT
    Methods Mol Biol; 2021; 2266():125-140. PubMed ID: 33759124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking optimization, variance and promiscuity for large-scale drug-like chemical space using high performance computing architectures.
    Trager RE; Giblock P; Soltani S; Upadhyay AA; Rekapalli B; Peterson YK
    Drug Discov Today; 2016 Oct; 21(10):1672-1680. PubMed ID: 27352630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streamlining Large Chemical Library Docking with Artificial Intelligence: the PyRMD2Dock Approach.
    Roggia M; Natale B; Amendola G; Di Maro S; Cosconati S
    J Chem Inf Model; 2024 Apr; 64(7):2143-2149. PubMed ID: 37552222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.